Veradermics Cash & Equivalents increased by 673.7% to $168.41M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalents| Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $53.08M | $32.44M | $21.77M | $168.41M |
| QoQ Change | — | -38.9% | -32.9% | +673.7% |
| YoY Change | — | — | -59.0% | +419.1% |